BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang W, Yu Y, Fang Y, Wang Y, Cui Y, Shen K, Liu T. Systemic chemotherapy as a main strategy for liver metastases from gastric cancer. Clin Transl Oncol. 2015;17:888-894. [PMID: 26108406 DOI: 10.1007/s12094-015-1321-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Huang R, Chen Z, Liu M, Deng Y, Li S, He N. The aptamers generated from HepG2 cells. Sci China Chem 2017;60:786-92. [DOI: 10.1007/s11426-016-0491-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
2 Zhou B, He N, Hong J, Yang T, Ng DM, Gao X, Yan K, Fan X, Zheng Z, Chen P, Zheng J, Zheng Q. HIFU for the treatment of gastric cancer with liver metastases with unsuitable indications for hepatectomy and radiofrequency ablation: a prospective and propensity score-matched study. BMC Surg 2021;21:308. [PMID: 34253213 DOI: 10.1186/s12893-021-01307-y] [Reference Citation Analysis]
3 Jiang H, Li Q, Yu S, Yu Y, Wang Y, Li W, Cui Y, Liu T. Impact of HER2 expression on outcome in gastric cancer patients with liver metastasis. Clin Transl Oncol 2017;19:197-203. [PMID: 27324991 DOI: 10.1007/s12094-016-1523-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
4 Temido MJ, Caetano Oliveira R, Martins R, Serôdio M, Costa B, Carvalho C, Santos E, Ferreira L, Teixeira P, Cipriano MA, Tralhão JG, Alexandrino H. Prognostic Factors After Hepatectomy for Gastric Adenocarcinoma Liver Metastases: Desmoplastic Growth Pattern as the Key to Improved Overall Survival. Cancer Manag Res 2020;12:11689-99. [PMID: 33244263 DOI: 10.2147/CMAR.S264586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Ikari N, Serizawa A, Mitani S, Yamamoto M, Furukawa T. Near-Comprehensive Resequencing of Cancer-Associated Genes in Surgically Resected Metastatic Liver Tumors of Gastric Cancer. The American Journal of Pathology 2019;189:784-96. [DOI: 10.1016/j.ajpath.2018.12.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
6 Kroese TE, van Laarhoven HWM, Nilsson M, Lordick F, Guckenberger M, Ruurda JP, D'Ugo D, Haustermans K, van Cutsem E, van Hillegersberg R, van Rossum PSN. Definition of oligometastatic esophagogastric cancer and impact of local oligometastasis-directed treatment: A systematic review and meta-analysis. Eur J Cancer 2022;166:254-69. [PMID: 35339868 DOI: 10.1016/j.ejca.2022.02.018] [Reference Citation Analysis]
7 Li Q, Li H, Jiang H, Feng Y, Cui Y, Wang Y, Ji Y, Yu Y, Li W, Xu C, Yu S, Zhuang R, Liu T. Predictive factors of trastuzumab-based chemotherapy in HER2 positive advanced gastric cancer: a single-center prospective observational study. Clin Transl Oncol 2018;20:695-702. [DOI: 10.1007/s12094-017-1772-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
8 Chen ZL, Zhao A, Li P, Zhang M, Yang J, Zhang L, Zhao X, Yang J, Wang L. Clinical use of trastuzumab combined with different chemotherapy regimens in multi-line treatment of advanced human epidermal growth factor receptor 2-positive gastric cancer: A case report. Oncol Lett 2018;16:4614-20. [PMID: 30214596 DOI: 10.3892/ol.2018.9212] [Reference Citation Analysis]
9 Wang SC, Xu J, Qiu JF. Surgical treatment of gastric cancer liver metastasis: Focus on controversy. Shijie Huaren Xiaohua Zazhi 2016; 24(33): 4450-4457 [DOI: 10.11569/wcjd.v24.i33.4450] [Reference Citation Analysis]